Titan Wealth CI Ltd purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 2,445 shares of the semiconductor company’s stock, valued at approximately $1,149,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in SNPS. Vanguard Group Inc. boosted its stake in shares of Synopsys by 1.6% during the 4th quarter. Vanguard Group Inc. now owns 18,464,862 shares of the semiconductor company’s stock worth $8,673,315,000 after acquiring an additional 283,677 shares in the last quarter. State Street Corp increased its stake in shares of Synopsys by 0.3% in the 4th quarter. State Street Corp now owns 8,788,890 shares of the semiconductor company’s stock valued at $4,128,317,000 after purchasing an additional 28,532 shares in the last quarter. Morgan Stanley increased its stake in shares of Synopsys by 2.5% in the 4th quarter. Morgan Stanley now owns 4,573,980 shares of the semiconductor company’s stock valued at $2,148,491,000 after purchasing an additional 109,917 shares in the last quarter. Geode Capital Management LLC raised its holdings in Synopsys by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 4,310,846 shares of the semiconductor company’s stock worth $2,017,256,000 after purchasing an additional 54,329 shares during the period. Finally, Victory Capital Management Inc. boosted its position in Synopsys by 238.8% during the third quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company’s stock worth $1,393,506,000 after purchasing an additional 1,990,608 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Insider Transactions at Synopsys
In other news, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares in the company, valued at $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by corporate insiders.
Synopsys Stock Down 1.3%
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. During the same quarter last year, the firm posted $3.67 EPS. The firm’s revenue for the quarter was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts forecast that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Several analysts have commented on the company. Morgan Stanley raised their price objective on Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a report on Thursday, May 28th. Piper Sandler increased their target price on Synopsys from $430.00 to $450.00 and gave the company a “neutral” rating in a research report on Thursday, May 28th. HSBC cut shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price target on the stock. in a research note on Friday, February 20th. Stifel Nicolaus boosted their price target on shares of Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Finally, KeyCorp reiterated an “overweight” rating on shares of Synopsys in a research report on Thursday, May 28th. Nine analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $563.81.
Read Our Latest Analysis on SNPS
Synopsys News Summary
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys announced a collaboration with Murata Manufacturing to expand access to simulation models through Synopsys/Ansys electromagnetic and thermal analysis tools, a move that could strengthen adoption of its design software and deepen customer usage. Murata Collaborates with Synopsys to Provide Simulation Models Through Ansys Electromagnetic and Thermal Analysis Tools
- Neutral Sentiment: A valuation note said SNPS looks “fairly valued” on a DCF basis around $394, suggesting the stock may not be deeply undervalued after its recent pullback. SNPS Fairly Valued by DCF at 394
- Neutral Sentiment: Brokerage coverage remains mixed, with the consensus rating still at “Hold” despite several higher price targets from analysts. Synopsys: Long-Term Opportunity Outweighs Near-Term Headwinds
- Negative Sentiment: Recent insider selling by top executives may be creating near-term pressure on the shares, even though the transactions were pre-planned and not necessarily a sign of weakening fundamentals. Top Synopsys Executive Makes Major Move With Insider Stock Sale
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- Could a Tesla-SpaceX Merger Be Closer Than Investors Think?
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
